Wogonin inhibits the proliferation of prolactinoma through the PI3K/AKT signaling pathway
These findings suggest that wogonin exerts its anti-prolactinoma effects via multiple targets and signaling cascades, establishing a robust scientific basis for the development and screening of novel anti-prolactinoma therapeutics.
Authors
- Cuiping Sun
- Xuechao Wu (ORCID: https://orcid.org/0000-0002-3655-0851)
- You Zhou (ORCID: https://orcid.org/0000-0003-3063-7654)
- Qing Wang (ORCID: https://orcid.org/0009-0003-7328-8762)
- Jiawei Wu (ORCID: https://orcid.org/0009-0008-3139-8273)
- Zhiyong Du
- Liping Shen
- Jing Wu (ORCID: https://orcid.org/0000-0002-8355-1953)
- Hongwei Gao (ORCID: https://orcid.org/0000-0002-1044-6511)
Institutions
- Jiangnan University (CN)
- Wuxi Institute of Technology (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.3389/fphar.2025.1546285
- Primary Topic
- Flavonoids in Medical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Jiangsu Provincial Key Research and Development Program